Cantor Fitzgerald Downgrades Collegium Pharmaceutical (COLL) to Neutral
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $27.11 -1.56%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes downgraded Collegium Pharmaceutical (NASDAQ: COLL) from Overweight to Neutral with a price target of $22.00.
For an analyst ratings summary and ratings history on Collegium Pharmaceutical click here. For more ratings news on Collegium Pharmaceutical click here.
Shares of Collegium Pharmaceutical closed at $24.84 yesterday.
You May Also Be Interested In
- Barclays flags an "attractive entry point" in this pharma stock
- TD Cowen Downgrades Roots Corp. (ROOT:CN) (RROTF) to Sell
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
